A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer

被引:0
作者
Daniel J. Renouf
Stephen Welch
Malcolm J. Moore
Monika K. Krzyzanowska
Jennifer Knox
Ronald Feld
Geoffrey Liu
Helen MacKay
Jennifer Petronis
Lisa Wang
Eric Chen
机构
[1] University Health Network-Princess Margaret Hospital,Department of Medical Oncology and Hematology
[2] London Regional Cancer Centre,Department of Medical Oncology
[3] Princess Margaret Hospital,Department of Biostatistics
[4] University Health Network,Department of Medical Oncology
[5] British Columbia Cancer Agency,undefined
来源
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词
Colorectal cancer; Capecitabine; Irinotecan; Bevacizumab; Phase II;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1339 / 1344
页数:5
相关论文
共 198 条
[91]  
Jonker DJ(undefined)undefined undefined undefined undefined-undefined
[92]  
O’Callaghan CJ(undefined)undefined undefined undefined undefined-undefined
[93]  
Karapetis CS(undefined)undefined undefined undefined undefined-undefined
[94]  
Zalcberg JR(undefined)undefined undefined undefined undefined-undefined
[95]  
Tu D(undefined)undefined undefined undefined undefined-undefined
[96]  
Au HJ(undefined)undefined undefined undefined undefined-undefined
[97]  
Van Cutsem E(undefined)undefined undefined undefined undefined-undefined
[98]  
Peeters M(undefined)undefined undefined undefined undefined-undefined
[99]  
Siena S(undefined)undefined undefined undefined undefined-undefined
[100]  
Humblet Y(undefined)undefined undefined undefined undefined-undefined